ACHE and Alzheimer disease: Unlike other major high morbidity and mortality disorders such as cancer and cardiovascular disease, AD patients have very limited therapeutic options that include the acetylcholinesterase inhibitors (ChEIs) rivastigmine, donepezil, and galantamine in addition to the N-methyl-d-aspartate (NMDA) receptor antagonist memantine [23].